Different cytokines induce surface lymphotoxin-αβ on IL-7 receptor-α cells that differentially engender lymph nodes and Peyer's patches

Immunity

Volumn 17, Issue 6, 2002, Pages 823-833

  Yoshida, Hisahiro ^a,b   Naito, Asuka ^c   Inoue, Jun Ichiro ^c   Satoh, Mizuho ^b   Santee Cooper, Sybil M ^d   Ware, Carl F ^d   Togawa, Atsushi ^b   Nishikawa, Satomi ^b   Nishikawa, Shin Ichi ^b  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 7; INTERLEUKIN RECEPTOR; INTERLEUKIN RECEPTOR ALPHA; LYMPHOTOXIN; LYMPHOTOXIN ALPHABETA; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEVELOPMENT; EMBRYO; LYMPH NODE; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0036906575     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00479-X     Document Type: Article

References (47)

1. Adachi S., Yoshida H., Kataoka H., Nishikawa S. Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol. 9:1997;507-514.
2. Adachi S., Yoshida H., Honda K., Maki K., Saijo K., Ikuta K., Saito T., Nishikawa S.I. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int. Immunol. 10:1998;1-6.
3. Alcamo E., Hacohen N., Schulte L.C., Rennert P.D., Hynes R.O., Baltimore D. Requirement for the NF-kappaB family member RelA in the development of secondary lymphoid organs. J. Exp. Med. 195:2002;233-244.
4. Alimzhanov M.B., Kuprash D.V., Kosco-Vilbois M.H., Luz A., Turetskaya R.L., Tarakhovsky A., Rajewsky K., Nedospasov S.A., Pfeffer K. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;9302-9307.
5. Banks T.A., Rouse B.T., Kerley M.K., Blair P.J., Godfrey V.L., Kuklin N.A., Bouley D.M., Thomas J., Kanangat S., Mucenski M.L. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J. Immunol. 155:1995;1685-1693.
6. Browning J.L., French L.E. Visualization of lymphotoxin-beta and lymphotoxin-beta receptor expression in mouse embryos. J. Immunol. 168:2002;5079-5087.
7. Cao X., Shores E.W., Hu-Li J., Anver M.R., Kelsall B.L., Russell S.M., Drago J., Noguchi M., Grinberg A., Bloom E.T. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity. 2:1995;223-238.
8. Crowe P.D., VanArsdale T.L., Walter B.N., Dahms K.M., Ware C.F. Production of lymphotoxin (LT alpha) and a soluble dimeric form of its receptor using the baculovirus expression system. J. Immunol. Methods. 168:1994;79-89.
9. Cuff C.A., Sacca R., Ruddle N.H. Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J. Immunol. 162:1999;5965-5972.
10. Dejardin E., Droin N.M., Delhase M., Haas H., Cao Y., Makris C., Li Z.-W., Karin M., Ware C.F., Green D.R. The lymphotoxin-β receptor pathway induces different patterns of gene expression via two NF-κB pathways. Immunity. 17:2002;525-535.
11. De Togni P., Goellner J., Ruddle N.H., Streeter P.R., Fick A., Mariathasan S., Smith S.C., Carlson R., Shornick L.P., Strauss-Schoenberger J.et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264:1994;703-707.
12. Dougall W.C., Glaccum M., Charrier K., Rohrbach K., Brasel K., De Smedt T., Daro E., Smith J., Tometsko M.E., Maliszewski C.R.et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 13:1999;2412-2424.
13. Force W.R., Walter B.N., Hession C., Tizard R., Kozak C.A., Browning J.L., Ware C.F. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression. J. Immunol. 155:1995;5280-5288.
14. Fu Y.X., Molina H., Matsumoto M., Huang G., Min J., Chaplin D.D. Lymphotoxin-alpha (LTalpha) supports development of splenic follicular structure that is required for IgG responses. J. Exp. Med. 185:1997;2111-2120.
15. Futterer A., Mink K., Luz A., Kosco-Vilbois M.H., Pfeffer K. The lymphotoxin β receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity. 9:1998;59-70.
16. Georgopoulos K., Bigby M., Wang J.H., Molnar A., Wu P., Winandy S., Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 79:1994;143-156.
17. Gonzalez M., Mackay F., Browning J.L., Kosco-Vilbois M.H., Noelle R.J. The sequential role of lymphotoxin and B cells in the development of splenic follicles. J. Exp. Med. 187:1998;997-1007.
18. Hashi H., Yoshida H., Honda K., Fraser S., Kubo H., Awane M., Takabayashi A., Nakano H., Yamaoka Y., Nishikawa S. Compartmentalization of Peyer's patch anlagen before lymphocyte entry. J. Immunol. 166:2001;3702-3709.
19. Honda K., Nakano H., Yoshida H., Nishikawa S., Rennert P., Ikuta K., Tamechika M., Yamaguchi K., Fukumoto T., Chiba T., Nishikawa S.I. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 193:2001;621-630.
20. Isaksen D.E., Baumann H., Trobridge P.A., Farr A.G., Levin S.D., Ziegler S.F. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J. Immunol. 163:1999;5971-5977.
21. Isaksen D.E., Baumann H., Zhou B., Nivollet S., Farr A.G., Levin S.D., Ziegler S.F. Uncoupling of proliferation and stat5 activation in thymic stromal lymphopoietin-mediated signal transduction. J. Immunol. 168:2002;3288-3294.
22. Kim D., Mebius R.E., MacMicking J.D., Jung S., Cupedo T., Castellanos Y., Rho J., Wong B.R., Josien R., Kim N.et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 192:2000;1467-1478.
23. Kong Y.Y., Boyle W.J., Penninger J.M. Osteoprotegerin ligand. a common link between osteoclastogenesis, lymph node formation and lymphocyte development Immunol. Cell Biol. 77:1999;188-193.
24. Koni P.A., Sacca R., Lawton P., Browning J.L., Ruddle N.H., Flavell R.A. Distinct roles in lymphoid organogenesis for lymphotoxins α and β revealed in lymphotoxin β-deficient mice. Immunity. 6:1997;491-500.
25. Luther S.A., Lopez T., Bai W., Hanahan D., Cyster J.G. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 12:2000;471-481.
26. Mebius R.E., Streeter P.R., Michie S., Butcher E.C., Weissman I.L. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+ CD3- cells to colonize lymph nodes. Proc. Natl. Acad. Sci. USA. 93:1996;11019-11024.
27. + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity. 7:1997;493-504.
28. Mebius R.E., Miyamoto T., Christensen J., Domen J., Cupedo T., Weissman I.L., Akashi K. The fetal liver counterpart of adult common lymphoid progenitors gives rise to all lymphoid lineages, CD45+CD4+CD3- cells, as well as macrophages. J. Immunol. 166:2001;6593-6601.
29. Naito A., Azuma S., Tanaka S., Miyazaki T., Takaki S., Takatsu K., Nakao K., Nakamura K., Katsuki M., Yamamoto T., Inoue J. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 4:1999;353-362.
30. Naito A., Yoshida H., Nishioka E., Satoh M., Azuma S., Yamamoto T., Nishikawa S., Inoue J. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc. Natl. Acad. Sci. USA. 99:2002;8766-8771.
31. Nishikawa S., Kusakabe M., Yoshinaga K., Ogawa M., Hayashi S., Kunisada T., Era T., Sakakura T. In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody. two distinct waves of c-kit-dependency during melanocyte development EMBO J. 10:1991;2111-2118.
32. Nishikawa S., Honda K., Hashi H., Yoshida H. Peyer's patch organogenesis as a programmed inflammation. a hypothetical model Cytokine Growth Factor Rev. 9:1998;213-220.
33. Pandey A., Ozaki K., Baumann H., Levin S.D., Puel A., Farr A.G., Ziegler S.F., Leonard W.J., Lodish H.F. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 1:2000;59-64.
34. Park S.Y., Saijo K., Takahashi T., Osawa M., Arase H., Hirayama N., Miyake K., Nakauchi H., Shirasawa T., Siato T. Development of lymphoid cells in Jak3 kinase-deficient mice. Immunity. 3:1995;771-782.
35. Rennert P.D., James D., Mackay F., Browning J.L., Hochman P.S. Lymph node genesis is induced by signaling through the lymphotoxin β receptor. Immunity. 9:1998;71-79.
36. Shinkura R., Kitada K., Matsuda F., Tashiro K., Ikuta K., Suzuki M., Kogishi K., Serikawa T., Honjo T. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 22:1999;74-77.
37. Sudo T., Nishikawa S., Ohno N., Akiyama N., Tamakoshi M., Yoshida H. Expression and function of the interleukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA. 90:1993;9125-9129.
38. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., Mebius R.E., Littman D.R. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science. 288:2000;2369-2373.
39. Takakura N., Yoshida H., Kunisada T., Nishikawa S., Nishikawa S.I. Involvement of platelet-derived growth factor receptor-alpha in hair canal formation. J. Invest. Dermatol. 107:1996;770-777.
40. Wong B.R., Josien R., Choi Y. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function. J. Leukoc. Biol. 65:1999;715-724.
41. Wu Q., Salomon B., Chen M., Wang Y., Hoffman L.M., Bluestone J.A., Fu Y.X. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 193:2001;1327-1332.
42. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A.et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA. 95:1998;3597-3602.
43. Yokota Y., Mansouri A., Mori S., Sugawara S., Adachi S., Nishikawa S., Gruss P. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature. 397:1999;702-706.
44. Yoshida H., Nishikawa S.-I., Okamura H., Sakakura T., Kusakabe M. The role of c-kit proto-oncogene during melanocyte development in mouse. In vivo approach by the in utero microinjection of anti-c-kit antibody. Dev. Growth Differ. 35:1993;209-220.
45. Yoshida H., Kunisada T., Kusakabe M., Nishikawa S., Nishikawa S.I. Distinct stages of melanocyte differentiation revealed by anlaysis of nonuniform pigmentation patterns. Development. 122:1996;1207-1214.
46. Yoshida H., Honda K., Shinkura R., Adachi S., Nishikawa S., Maki K., Ikuta K., Nishikawa S.I. IL-7 receptor alpha+ CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol. 11:1999;643-655.
47. Yoshida H., Kawamoto H., Santee S.M., Hashi H., Honda K., Nishikawa S., Ware C.F., Katsura Y., Nishikawa S.I. Expression of alpha(4)beta(7) integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J. Immunol. 167:2001;2511-2521.